The New Zealand dollar continued to climb as a wave of optimism about the prospects for a Covid-19 vaccine swept the financial world.
The kiwi was trading at 60.45 US cents at 5pm in Wellington from 59.50 cents at the same time yesterday. The trade-weighted index was at 68.32 from 67.55.
US biotech company Moderna reported that a small first study of its experimental vaccine designed to look at its safety had resulted in no major concerns and also showed the vaccine can create an immune system response.
Despite the very early stage of testing its vaccine, Moderna shares surged as much as 30 per cent while the Dow Jones Index rose nearly 4 per cent. As is usual when risk appetite sharpens, the kiwi went along for the ride.
Mike Shirley, a dealer at Kiwibank, said it wasn't a complete switch from safe havens to riskier assets – he noted that the price of gold fell a little but soon began to recover.